Skip to main content
. 2014 Sep 10;5(19):8924–8936. doi: 10.18632/oncotarget.2441

Figure 3. The mouse toxicity assay for p53 deficient and wildtype mice followed by Decitabine IP injections.

Figure 3

The comparison between p53KO mice and wildtype mice (A) or between p53r270h mice and wildtype mice (B) or between p53KO mice and p53r270h mice (C) or merged all curves (D). p53KO(red), p53r270h(blue) & wildtype (black)